Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1093500

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1093500

Europe Postpartum Hemorrhage (PPH) Devices Market Size, Share & Industry Trends Analysis Report By Product (Uterine Tamponade Devices, Prefilled Injection System, and Non-Pneumatic Anti-Shock Garment), By Country and Growth Forecast, 2022 - 2028

PUBLISHED:
PAGES: 56 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Site License)
USD 1800
PDF (Enterprisewide License)
USD 2520

Add to Cart

The Europe Postpartum Hemorrhage (PPH) Devices Market would witness market growth of 5.0% CAGR during the forecast period (2022-2028).

After giving birth, a woman may experience postpartum hemorrhage. It's a dangerous yet uncommon disorder. It normally occurs within one day of giving birth, however, it can occur up to 12 weeks later. Postpartum hemorrhage affects 1 to 5 out of every 100 (1 to 5%) women who give birth. After giving delivery, it's usual to lose some blood. During vaginal birth, women lose about half a quart (500 milliliters), and following a cesarean birth (also called c-section), they lose about a quart (1,000 milliliters). A c-section is a procedure in which the baby is delivered through a cut in the tummy and uterus made by an obstetrician. Postpartum hemorrhage causes the mother to lose a lot more blood, which is why it's such a dangerous condition. Postpartum hemorrhage can result in a significant reduction in blood pressure. This can result in shock and death if not addressed promptly. Shock occurs when blood supply to the body organs is insufficient.

The most common cause of PPH when the uterus' muscles do not contract (tighten) properly after birth. After a baby is born, uterine contractions help to stop bleeding from the site where the placenta separates from the uterus. If the uterus is stretched or enlarged (sometimes termed distended) after giving birth to twins or a large kid, the mother may have uterine atony (more than 8 pounds, 13 ounces). It can also happen if one has had numerous children, are in labor for an extended period of time, or have too much amniotic fluid. The fluid that surrounds the baby in the womb is called amniotic fluid.

In Europe, postpartum hemorrhage (PPH) is still a leading cause of maternal mortality and morbidity. It is the third largest cause of maternal death in the United Kingdom, as well as the most common reason for obstetric-related critical care hospitalizations.

In the United Kingdom, the prevalence of primary PPH has steadily increased, reaching 13.8 percent in 2012-2013. Because of its complicated origin, early detection and treatment remain critical to lowering the incidence of PPH. According to the current Confidential Enquiries into Maternal Deaths and Morbidity in the United Kingdom, there are significant differences in how obstetric bleeding situations are managed, which leads to greater morbidity. National guidelines have been produced to standardize care and give doctors and healthcare professionals a clear evidence-based framework to address this significant health concern. Despite this, the implementation of these standards in clinical practice is still lacking. The high rate of postpartum hemorrhage in the region is likely to lead to high demand for postpartum hemorrhage devices.

The Germany market dominated the Europe Postpartum Hemorrhage (PPH) Devices Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $68.9 Million by 2028. The UK market is experiencing a CAGR of 4.1% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 5.7% during (2022 - 2028).

Based on Product, the market is segmented into Uterine Tamponade Devices, Prefilled Injection System, and Non-Pneumatic Anti-Shock Garment. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Teleflex, Inc., Becton, Dickinson and Company, Bactiguard Holding AB, Utah Medical Products, Inc., Organon & Co., Cook Medical, Inc., PATH, Obstetrx, Inc., Zoex Corporation, and 3rd Stone Design, Inc.

Scope of the Study

Market Segments covered in the Report:

By Product

  • Uterine Tamponade Devices
  • Prefilled Injection System
  • Non-Pneumatic Anti-Shock Garment

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Companies Profiled

  • Teleflex, Inc.
  • Becton, Dickinson and Company
  • Bactiguard Holding AB
  • Utah Medical Products, Inc.
  • Organon & Co.
  • Cook Medical, Inc.
  • PATH
  • Obstetrx, Inc.
  • Zoex Corporation
  • 3rd Stone Design, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Europe Postpartum Hemorrhage (PPH) Devices Market, by Product
    • 1.4.2 Europe Postpartum Hemorrhage (PPH) Devices Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Europe Postpartum Hemorrhage (PPH) Devices Market by Product

  • 3.1 Europe Uterine Tamponade Devices Market by Country
  • 3.2 Europe Prefilled Injection System Market by Country
  • 3.3 Europe Non-Pneumatic Anti-Shock Garment Market by Country

Chapter 4. Europe Postpartum Hemorrhage (PPH) Devices Market by Country

  • 4.1 Germany Postpartum Hemorrhage (PPH) Devices Market
    • 4.1.1 Germany Postpartum Hemorrhage (PPH) Devices Market by Product
  • 4.2 UK Postpartum Hemorrhage (PPH) Devices Market
    • 4.2.1 UK Postpartum Hemorrhage (PPH) Devices Market by Product
  • 4.3 France Postpartum Hemorrhage (PPH) Devices Market
    • 4.3.1 France Postpartum Hemorrhage (PPH) Devices Market by Product
  • 4.4 Russia Postpartum Hemorrhage (PPH) Devices Market
    • 4.4.1 Russia Postpartum Hemorrhage (PPH) Devices Market by Product
  • 4.5 Spain Postpartum Hemorrhage (PPH) Devices Market
    • 4.5.1 Spain Postpartum Hemorrhage (PPH) Devices Market by Product
  • 4.6 Italy Postpartum Hemorrhage (PPH) Devices Market
    • 4.6.1 Italy Postpartum Hemorrhage (PPH) Devices Market by Product
  • 4.7 Rest of Europe Postpartum Hemorrhage (PPH) Devices Market
    • 4.7.1 Rest of Europe Postpartum Hemorrhage (PPH) Devices Market by Product

Chapter 5. Company Profiles

  • 5.1 Teleflex, Inc.
    • 5.1.1 Company Overview
    • 5.1.2 Financial Analysis
    • 5.1.3 Segmental and Regional Analysis
    • 5.1.4 Research & Development Expense
  • 5.2 Becton, Dickinson and Company
    • 5.2.1 Company Overview
    • 5.2.2 Financial Analysis
    • 5.2.3 Segmental and Regional Analysis
    • 5.2.4 Research & Development Expense
  • 5.3 Bactiguard Holding AB
    • 5.3.1 Company Overview
    • 5.3.2 Financial Analysis
    • 5.3.3 Regional Analysis
  • 5.4 Utah Medical Products, Inc.
    • 5.4.1 Company Overview
    • 5.4.2 Financial Analysis
    • 5.4.3 Regional Analysis
    • 5.4.4 Research & Development Expense
  • 5.5 Organon & Co.
    • 5.5.1 Company Overview
    • 5.5.2 Financial Analysis
    • 5.5.3 Regional Analysis
    • 5.5.4 Research & Development Expenses
    • 5.5.5 Recent strategies and developments:
      • 5.5.5.1 Approvals and Trials:
      • 5.5.5.2 Acquisition and Mergers:
  • 5.6 Cook Medical, Inc. (Cook Group)
    • 5.6.1 Company Overview
  • 5.7 PATH
    • 5.7.1 Company Overview
    • 5.7.2 Financial Analysis
    • 5.7.3 Recent strategies and developments:
      • 5.7.3.1 Product Launches and Product Expansions:
  • 5.8 Obstetrx, Inc.
    • 5.8.1 Company Overview
  • 5.9 Zoex Corporation
    • 5.9.1 Company Overview
  • 5.10. 3rd Stone Design, Inc.
    • 5.10.1 Company Overview

LIST OF TABLES

  • TABLE 1 Europe Postpartum Hemorrhage (PPH) Devices Market, 2018 - 2021, USD Million
  • TABLE 2 Europe Postpartum Hemorrhage (PPH) Devices Market, 2022 - 2028, USD Million
  • TABLE 3 Europe Postpartum Hemorrhage (PPH) Devices Market by Product, 2018 - 2021, USD Million
  • TABLE 4 Europe Postpartum Hemorrhage (PPH) Devices Market by Product, 2022 - 2028, USD Million
  • TABLE 5 Europe Uterine Tamponade Devices Market by Country, 2018 - 2021, USD Million
  • TABLE 6 Europe Uterine Tamponade Devices Market by Country, 2022 - 2028, USD Million
  • TABLE 7 Europe Prefilled Injection System Market by Country, 2018 - 2021, USD Million
  • TABLE 8 Europe Prefilled Injection System Market by Country, 2022 - 2028, USD Million
  • TABLE 9 Europe Non-Pneumatic Anti-Shock Garment Market by Country, 2018 - 2021, USD Million
  • TABLE 10 Europe Non-Pneumatic Anti-Shock Garment Market by Country, 2022 - 2028, USD Million
  • TABLE 11 Europe Postpartum Hemorrhage (PPH) Devices Market by Country, 2018 - 2021, USD Million
  • TABLE 12 Europe Postpartum Hemorrhage (PPH) Devices Market by Country, 2022 - 2028, USD Million
  • TABLE 13 Germany Postpartum Hemorrhage (PPH) Devices Market, 2018 - 2021, USD Million
  • TABLE 14 Germany Postpartum Hemorrhage (PPH) Devices Market, 2022 - 2028, USD Million
  • TABLE 15 Germany Postpartum Hemorrhage (PPH) Devices Market by Product, 2018 - 2021, USD Million
  • TABLE 16 Germany Postpartum Hemorrhage (PPH) Devices Market by Product, 2022 - 2028, USD Million
  • TABLE 17 UK Postpartum Hemorrhage (PPH) Devices Market, 2018 - 2021, USD Million
  • TABLE 18 UK Postpartum Hemorrhage (PPH) Devices Market, 2022 - 2028, USD Million
  • TABLE 19 UK Postpartum Hemorrhage (PPH) Devices Market by Product, 2018 - 2021, USD Million
  • TABLE 20 UK Postpartum Hemorrhage (PPH) Devices Market by Product, 2022 - 2028, USD Million
  • TABLE 21 France Postpartum Hemorrhage (PPH) Devices Market, 2018 - 2021, USD Million
  • TABLE 22 France Postpartum Hemorrhage (PPH) Devices Market, 2022 - 2028, USD Million
  • TABLE 23 France Postpartum Hemorrhage (PPH) Devices Market by Product, 2018 - 2021, USD Million
  • TABLE 24 France Postpartum Hemorrhage (PPH) Devices Market by Product, 2022 - 2028, USD Million
  • TABLE 25 Russia Postpartum Hemorrhage (PPH) Devices Market, 2018 - 2021, USD Million
  • TABLE 26 Russia Postpartum Hemorrhage (PPH) Devices Market, 2022 - 2028, USD Million
  • TABLE 27 Russia Postpartum Hemorrhage (PPH) Devices Market by Product, 2018 - 2021, USD Million
  • TABLE 28 Russia Postpartum Hemorrhage (PPH) Devices Market by Product, 2022 - 2028, USD Million
  • TABLE 29 Spain Postpartum Hemorrhage (PPH) Devices Market, 2018 - 2021, USD Million
  • TABLE 30 Spain Postpartum Hemorrhage (PPH) Devices Market, 2022 - 2028, USD Million
  • TABLE 31 Spain Postpartum Hemorrhage (PPH) Devices Market by Product, 2018 - 2021, USD Million
  • TABLE 32 Spain Postpartum Hemorrhage (PPH) Devices Market by Product, 2022 - 2028, USD Million
  • TABLE 33 Italy Postpartum Hemorrhage (PPH) Devices Market, 2018 - 2021, USD Million
  • TABLE 34 Italy Postpartum Hemorrhage (PPH) Devices Market, 2022 - 2028, USD Million
  • TABLE 35 Italy Postpartum Hemorrhage (PPH) Devices Market by Product, 2018 - 2021, USD Million
  • TABLE 36 Italy Postpartum Hemorrhage (PPH) Devices Market by Product, 2022 - 2028, USD Million
  • TABLE 37 Rest of Europe Postpartum Hemorrhage (PPH) Devices Market, 2018 - 2021, USD Million
  • TABLE 38 Rest of Europe Postpartum Hemorrhage (PPH) Devices Market, 2022 - 2028, USD Million
  • TABLE 39 Rest of Europe Postpartum Hemorrhage (PPH) Devices Market by Product, 2018 - 2021, USD Million
  • TABLE 40 Rest of Europe Postpartum Hemorrhage (PPH) Devices Market by Product, 2022 - 2028, USD Million
  • TABLE 41 key Information - Teleflex, Inc.
  • TABLE 42 Key information - Becton, Dickinson and Company
  • TABLE 43 Key Information - Bactiguard Holding AB
  • TABLE 44 Key Information - Utah Medical Products, Inc.
  • TABLE 45 Key Information - Organon & Co.
  • TABLE 46 key Information - Cook Medical, Inc.
  • TABLE 47 Key Information - PATH
  • TABLE 48 Key Information - Obstetrx, Inc.
  • TABLE 49 Key Information - Zoex Corporation
  • TABLE 50 Key Information - 3rd Stone Design, Inc.

List of Figures

  • FIG 1 Methodology for the research
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!